Sk Biopharmaceuticals Co., Ltd.

Hye Kyung Min

Ji Won Lee

Jin Yong Chung

Ji Yeon Kim

Ju Young Lee

Chan Mi Joung

Eun Ju Choi

Young Koo Jang

Cheol Young Maeng

Nahm Ryune Cho

Yong Je Shin

Eun Ju Ryu

Hyo Jun Jung

Jong Sil Park

Chun Eung Park

Seung Nam Han

Seung Mo Ham

Soo Bong Cha

Yong Gil Kim

Yeo Jin Yoon

Joo Young Park

In Suk Park

Cheol Hyoung Park

Mi Jung Lim

The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same

The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same:  The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Provided is a pharmaceutical composition for inhibiting apoptosis of neurons or neurodegeneration. The pharmaceutical composition effectively prevents or treats diseases related to apoptosis of neurons or neurodegeneration.

Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration

Growing community of inventors

Daejeon, South Korea

Hye Kyung Min